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The objective of this study is to develop a novel system for 
acyclovir (ACV) controlled release after cutaneous application 
through the encapsulation of the drug into polymeric nanofibers of 
policaprolactone (PCL) produced by the electrospinning technique 
to overcome the limitations of the conventional topical  
formulations.  
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ACV:     intermediate/low aqueous solubility  
       permeability in biological tissues   
   Low bioavailability in the organism  
 
        repeated administration of high doses   
Solution  
Composition 
Parameters of 
Electrospinning 
Characterization 
Methods  
[ACV] = 2x10-2 g.mL-1 
[PCL] = 1.2x10-1g.mL-1 
Voltage = 15 kV Flow Rate = 0.6 mL.h-1 
Needle diameter 23 G 
Distance (spinneret-collector) = 12 cm 
Room temperature 
Evaluation of nanofiber morphology/composition  
Cell viability assays (MTT assay)  
Controlled release assays at physiological        
conditions (pH 5.5 and 37 ºC) in aqueous or in            
micellar environment (to mimic the biological       
interface).  
RESULTS and DISCUSSION: 
CONCLUSION: 
The electrospinning technique was efficient in producing ACV-loaded nanofibers, being a 
promising approach to reach a more sustained drug release profile. Moreover, the biological  
interface (micellar environment) showed to be an important parameter in allowing the assess-
ment of ACV controlled release. 
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ELEMENTAL ANALYSIS (SEM-EDS)  
Visualization of  PCL + ACV nanofibers by 
Scanning Electron Microscopy with Energy-
Dispersive X-ray Spectroscopy (SEM-EDS) 
with 15 kV, dimensions 380 x 380 µm. 
COMPOSITION OF NANOFIBER BY X-RAY DIFFRACTION  
ACV 
PCL 
Viability of epidermal keratinocytes - HaCaT (left) and human foreskin fibroblasts HFF-1 (right) assessed by the MTT assay after 24 h  
incubation with extracts of PCL fibers and hydrophilic gauze. Columns represent mean values and error bars the standard deviation (n=3).  
The SEM-EDS shows the presence of ACV in the nanofiber. 
The nanofibers produced have an average size of 595 nm. 
CELL VIABILITY  
The nanofibers presented acceptable cell viability up to a concentration of 25 mg/mL.  
Diffractogram of the samples: PCL powder, ACV powder and PCL + ACV nanofibers. 
The X-ray diffraction 
shows the presence of 
ACV in the nanofiber 
CONTROL RELEASE ASSAYS 
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The ACV release profile of the nanofibers in micellar environment is more sustained and 
more pronounced (when compared to the aqueous environment and the commercial  
formulation). 
Drug Loading = 3.45% Drug Loading = 10.90%  
 
Release profile of ACV: Commercial cream formulation (left) and nanofiber formulation (right) in aqueous environment and micellar 
environment. 
 Governo da República Portuguesa  
